Diagnostics manufacturers have, so far, dodged a lot of heat from Capitol Hill. But the makers of point-of-care diagnostics ought to seriously consider the possibility that their turn in the spotlight may be approaching. Read about it in tomorrow's edition of MDD Perspectives, an op-ed e-zine that provides fresh commentary and opinions on issues that you can't find anywhere else. And best of all, it's free. If you don't already subscribe to this complimentary e-zine, go to medicaldevicedaily.com to sign up.